tiprankstipranks
TipRanksTop Financial ExpertsInsidersWellington Biomedical Innovation Master Investors

Wellington Biomedical Innovation Master Investors Insider Profile

4 Followers
Wellington Biomedical Innovation Master Investors , Ten Percent Owner at Black Diamond Therapeutics, holds 556.23K shares in Boundless Bio Inc. (Ticker: BOLD), holds 897.67K shares in Nuvalent (Ticker: NUVL), holds 2.50M shares in Verve Therapeutics (Ticker: VERV).
tipranks
Wellington Biomedical Innovation Master Investors

Wellington Biomedical Innovation Master Investors
Black Diamond Therapeutics (BDTX)
Ten Percent Owner

Ranked #63,211 out of 98,909 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-15.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$211M
28.14%
20.31%
17.45%
7.55%
26.55% Others
A breakdown of Wellington Biomedical Innovation Master Investors 's holdings

Insider Roles

Nuvalent
(NUVL)
Ten Percent Owner
Dyne Therapeutics
(DYN)
Ten Percent Owner
Kymera Therapeutics
(KYMR)
Ten Percent Owner
Olema Pharmaceuticals
(OLMA)
Ten Percent Owner
+8 other positions
Roles that Wellington Biomedical Innovation Master Investors holds in companies

Most Profitable Insider Trade

Stock:
Generation Bio
(GBIO)
Rating:Informative Buy
Date:Jun 18, 2020 - Jun 18, 2021
Return:+12.40%
The most profitable trade made by Wellington Biomedical Innovation Master Investors

Wellington Biomedical Innovation Master Investors 's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Black Diamond Therapeutics
Feb 05, 2020
Ten Percent Owner
Uninformative Buy
$3.38M
Generation Bio
Jun 18, 2020
Ten Percent Owner
Uninformative Buy
$6.00M
FMTX
Forma Therapeutics Holdings
Jun 25, 2020
Uninformative Buy
$45.08M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
$10.93M
Kymera Therapeutics
Aug 27, 2020
Ten Percent Owner
Uninformative Buy
$36.80M
Dyne Therapeutics
Sep 23, 2020
Ten Percent Owner
Uninformative Buy
$42.83M
PMV Pharmaceuticals
Sep 29, 2020
Former 10% Owner
Uninformative Buy
$1.62M
Aligos Therapeutics
Oct 22, 2020
Ten Percent Owner
Uninformative Buy
$1.30M
Olema Pharmaceuticals
Nov 24, 2020
Ten Percent Owner
Uninformative Buy
$15.91M
Edgewise Therapeutics
Mar 30, 2021
Ten Percent Owner
Uninformative Buy
$11.92M
Verve Therapeutics
Jun 22, 2021
Ten Percent Owner
Uninformative Buy
$15.52M
Nuvalent
Aug 03, 2021
Ten Percent Owner
Uninformative Buy
$59.32M
Boundless Bio Inc.
Apr 02, 2024
Ten Percent Owner
Uninformative Buy
$5.30M
List of latest transactions for each holding click on a transaction to see Wellington Biomedical Innovation Master Investors 's performance on stock

Wellington Biomedical Innovation Master Investors insider profile FAQ

What is the percentage of profitable transactions made by Wellington Biomedical Innovation Master Investors ?
The percentage of profitable transactions made by Wellington Biomedical Innovation Master Investors is 50%.
    What is the average return per transaction made by Wellington Biomedical Innovation Master Investors ?
    The average return per transaction made by Wellington Biomedical Innovation Master Investors is -15.40%.
      What stocks does Wellington Biomedical Innovation Master Investors hold?
      Wellington Biomedical Innovation Master Investors holds: BDTX, GBIO, FMTX, NRIX, KYMR, DYN, PMVP, ALGS, OLMA, EWTX, VERV, NUVL, BOLD stocks.
        What was Wellington Biomedical Innovation Master Investors ’s latest transaction?
        Wellington Biomedical Innovation Master Investors latest transaction was an Uninformative Buy of ―.
          What was Wellington Biomedical Innovation Master Investors 's most profitable transaction?
          Wellington Biomedical Innovation Master Investors ’s most profitable transaction was an Informative Buy of GBIO stock on June 18, 2020. The return on the trade was 12.40%.
            What is Wellington Biomedical Innovation Master Investors 's role in Black Diamond Therapeutics?
            Wellington Biomedical Innovation Master Investors 's role in Black Diamond Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.